Sunday, December 21, 2014
YOLO COUNTY NEWS
99 CENTS

UCD vets eye drug treatment for deadly horse disease

Alonso Guedes, an assistant professor of veterinary medicine, rescued Hulahalla, this 4-year-old thoroughbred mare, from the brink of death by administering an experimental anti-inflammatory drug to treat laminitis, an agonizingly painful foot disease. Don Preisler, UC Davis/Courtesy photo

By
From page A4 | November 23, 2012 |

UC Davis veterinarians have announced plans to conduct the first clinical trial of an experimental drug that has shown promise in treating horses stricken with laminitis, an excruciatingly painful and often life-threatening foot-related disease.

Four horses suffering from laminitis have been treated with the investigational anti-inflammatory drug so far. One experienced a complete remission that has lasted for more than a year, and three others have shown some improvement.

A paper on the first laminitis case has been accepted for publication by the peer-reviewed Journal of Veterinary Anaesthesia and Analgesia. The paper is expected to be published in the journal’s February issue, but journal editors authorized the authors to disclose their findings ahead of publication.

“This is an unusual step for us to announce this so far in advance, but because euthanasia is often the only way to alleviate pain in severe laminitis, we felt that it was important to let the veterinarians and horse owners know that this compound has shown potential as a treatment,” said Alonso Guedes, an assistant professor in the School of Veterinary Medicine.

The horses were treated under a “compassionate use” protocol approved by the UCD Institutional Animal Care and Use Committee. That protocol allows animals to be treated with an experimental drug if no approved alternative treatment exists.

A clinical trial to assess the drug’s safety and establish a tolerable dose for the compound is expected to begin in the spring. Further clinical trials would be needed to establish the drug’s effectiveness as a laminitis treatment.

The experimental compound, known as t-TUCB, belongs to a group of anti-inflammatory compounds called sEH (soluble epoxide hydrolases) inhibitors. It stems from a discovery made more than 40 years ago by entomology professor Bruce Hammock while doing basic insect biology research.

Originally interested in finding biological insect control methods, Hammock has since broadened his research to also search for biomedical applications. He and colleagues have identified a group of anti-inflammatory compounds, including the sEH inhibitors, that have proven to be effective in relieving inflammatory discomfort and pain related to nervous system disorders in mice and rats. Their work has been published in scientific journals including the Proceedings of the National Academy of Sciences and the Journal of Medicinal Chemistry.

Laminitis is a poorly understood condition involving inflammation of a horse’s nailbed — the connective tissue where the horse’s hoof and lower foot bone join. The inflammation is usually accompanied by swelling, a restriction of the blood supply to that area, high blood pressure, lameness and extreme pain.

Guedes noted that the safe management of laminitis-related pain is one of the biggest challenges for equine veterinarians. Often, euthanasia is the only humane alternative for alleviating pain and suffering in horses afflicted with the condition.

Consequently, the survival rate for laminitis is estimated to be only 25 percent. Very few surviving horses return to their previous levels of activity, and laminitis often reappears.

In his upcoming paper, Guedes reports the case of a 4-year old thoroughbred mare named Hulahalla that developed laminitis. The horse had been retired from racing following a tendon injury and donated to the UCD School of Veterinary Medicine, where it was participating in a study focused on healing tendon injuries using stem cell treatments.

Veterinarians from UCD’s William R. Pritchard Veterinary Medical Teaching Hospital treated the laminitis with conventional therapies including cold immersion, antibiotics, leg wraps, and two commonly used nonsteroidal drugs intended to reduce inflammation and relieve pain — but the horse only got worse. At the point that the mare was spending most of the day lying down, Guedes got involved.

Before resorting to euthanasia, Guedes and the veterinary team decided to try one last treatment, t-TUCB.

The veterinarians administered the experimental compound intravenously early on the eighth day of Hulahalla’s illness. After receiving the first dose, the horse remained standing in the stall most of the day, became interested in her surroundings and walked voluntarily.

The mare’s demeanor, posture and mobility continued to improve over four days of treatment, and her high blood pressure gradually returned to normal. No adverse affects from t-TUCB were observed, and Hulahalla has remained laminitis-free for a full year.

The sEH inhibitors, including t-TUCB, are currently available from the Hammock lab, which has provided the experimental compounds to more than 100 academic scientists around the world for basic investigation into their role in treating disease.

Hammock said that work aimed at moving t-TUCB and related compounds toward clinical use is advancing in several areas. He and Guedes are working on compounds with potential for targeting pain and arthritis in companion animals. And they are working with UCD to move the intellectual property from this research into a company to develop medications for difficult-to-manage neuropathic pain associated with diabetes and nerve injury.

Funding was provided by the National Institute of Environmental Health Sciences and the UCD Center for Equine Health.

— UC Davis News Service

Comments

comments

  • Recent Posts

  • Enter your email address to subscribe to this newspaper and receive notifications of new articles by email.

  • .

    News

     
    What’s new at UCD? Construction projects abound

    By Tanya Perez | From Page: A1 | Gallery

    No-nonsense Musser voted Citizen of the Year

    By Dave Ryan | From Page: A1 | Gallery

     
    Sharing a meal, and so much more

    By Anne Ternus-Bellamy | From Page: A1 | Gallery

    Brinley Plaque honors environmental stalwart

    By Dave Ryan | From Page: A1 | Gallery

     
    North Korea proposes joint probe over Sony hacking

    By The Associated Press | From Page: A2

    AP sources: Cops’ killer angry over Garner death

    By The Associated Press | From Page: A2

     
    Raul Castro: Don’t expect detente to change Cuban system

    By The Associated Press | From Page: A2

    Police seek help in finding runaway twin girls

    By Enterprise staff | From Page: A2

     
    Downtown crash results in DUI arrest

    By Lauren Keene | From Page: A2

    March trial date set in Davis molest case

    By Lauren Keene | From Page: A2

     
    Enterprise plans Christmas, New Year’s holiday hours

    By Enterprise staff | From Page: A3

     
     
    Luminaria display planned in West Davis

    By Enterprise staff | From Page: A3

    Soup’s On will benefit NAMI-Yolo

    By Enterprise staff | From Page: A3

     
    Pedal around Davis on weekly bike ride

    By Enterprise staff | From Page: A3

     
    Supplies collected for victims of abuse

    By Enterprise staff | From Page: A3

    Donors, volunteers honored on Philanthropy Day

    By Special to The Enterprise | From Page: A3 | Gallery

     
    Surprise honor is really nice, dude

    By Enterprise staff | From Page: A5 | Gallery

     
    Konditorei presents free holiday concert

    By Enterprise staff | From Page: A5

    .

    Forum

     
    E-cigs surpass regular cigarettes among teens

    By The Associated Press | From Page: B4

    It’s not a pretty picture

    By Creators Syndicate | From Page: B4

     
    Google me this: Should I hit that button?

    By Marion Franck | From Page: B4

    Too late to pick a fight

    By Creators Syndicate | From Page: B5

     
    All police need to humanize

    By Letters to the Editor | From Page: A10

    Are we only a fair-weather bike city?

    By Letters to the Editor | From Page: A10

     
    Join us in making our world more just

    By Special to The Enterprise | From Page: A10

     
    Tom Meyer cartoon

    By Debbie Davis | From Page: A10

    The electronic equivalent of war

    By Special to The Enterprise | From Page: A11

     
    The Green House effect: Homes where the elderly thrive

    By New York Times News Service | From Page: A11

    .

    Sports

     
    Stenz shines as DHS girls take a tournament title

    By Enterprise staff | From Page: B1 | Gallery

    Aggie Manzanares not quite finished carrying the rock

    By Bruce Gallaudet | From Page: B1 | Gallery

     
    UCD women look to improve, despite game at No. 7 Stanford

    By Bruce Gallaudet | From Page: B1 | Gallery

    Second-half run spurs Aggie men to 8-1

    By Enterprise staff | From Page: B1

     
    49ers fall to San Diego in overtime

    By The Associated Press | From Page: B10

    .

    Features

    .

    Arts

    .

    Business

    Marrone Bio expands its product reach in Latin America

    By Enterprise staff | From Page: A4

     
    Sierra Northern Railway names CEO

    By Special to The Enterprise | From Page: A4

    Sink your teeth into Vampire Penguin

    By Wendy Weitzel | From Page: A4 | Gallery

     
    .

    Obituaries

    .

    Comics

    Comics: Sunday, December 21, 2014

    By Creator | From Page: B8